Alexandria Real Estate Equities
ARE
$124.17
Share price
0.09%
Change (1 day)
6.21%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Alexandria Real Estate Equities (ARE) - Total debt
Total debt on the balance sheet as of March 2024 : $12.59 B
According to Alexandria Real Estate Equities 's latest financial reports the company's total debt is $12.59 B. A company’s total debt is the sum of all current and non-current debts.
Alexandria Real Estate Equities - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $11.69 B | 10.71% |
| 2022-12-31 | $10.56 B | 14.52% |
| 2021-12-31 | $9.22 B | 16.66% |
| 2020-12-31 | $7.90 B | 12.2% |
| 2019-12-31 | $7.04 B | 28.68% |
| 2018-12-31 | $5.47 B | 14.97% |
| 2017-12-31 | $4.76 B | 14.43% |
| 2016-12-31 | $4.16 B | 5.8% |
| 2015-12-31 | $3.93 B | 6.99% |
| 2014-12-31 | $3.67 B | 20.17% |
| 2013-12-31 | $3.06 B | -3.8% |
| 2012-12-31 | $3.18 B | 14.49% |
| 2011-12-31 | $2.77 B | 7.55% |
| 2010-12-31 | $2.58 B | -5.93% |
| 2009-12-31 | $2.74 B | -6.51% |
| 2008-12-31 | $2.93 B | 5.39% |
| 2007-12-31 | $2.78 B | 37.68% |
| 2006-12-31 | $2.02 B | 43.95% |
| 2005-12-31 | $1.40 B | 18.51% |
| 2004-12-31 | $1.18 B | 67.41% |
| 2003-12-31 | $0.70 B | 15.31% |
| 2002-12-31 | $0.61 B | 7.28% |
| 2001-12-31 | $0.57 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 462.32% | 🇺🇸 USA |
 Eli Lilly LLY | $26.21 B | 108.05% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 412.85% | 🇺🇸 USA |
 Gilead Sciences GILD | $24.98 B | 98.33% | 🇺🇸 USA |
 Illumina ILMN | $2.26 B | -82.05% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 355.67% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $1.30 B | -89.67% | 🇺🇸 USA |